| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH | TABLE OF CONTENTS |
RESEARCH |
1 Departments of Clinical and Population Sciences and 2 Animal Science, University of Minnesota, St Paul, 495 ASVM Building, 1988 Fitch Avenue, Minnesota 55108, USA and 3 Department of Large Animal Clinical Sciences, University of Florida, Gainesville, Florida 32618, USA
Correspondence should be addressed to A S Alghamdi; Email: algh0007{at}umn.edu
| Abstract |
|---|
|
|
|---|
| Introduction |
|---|
|
|
|---|
Seminal plasma has been associated with immunosuppressive activities in many species including the horse (Anderson & Tarter 1982, Schope et al. 1984, Bouvet et al. 1987, Troedsson et al. 1995a,b, 2000, Imade et al. 1997, Rozeboom et al. 1999, 2000, 2001). We have previously demonstrated that SP significantly reduced the proportion of spermatozoa phagocytosed by PMNs, although the mechanisms were not determined. In order for spermatozoa to undergo phogocytosis by PMNs, sperm cells must first bind to the surface of PMNs, which can be mediated by the opsonization of spermatozoa, or by a specific receptor-ligand binding mechanism. We hypothesize that SP suppresses phagocytosis of spermatozoa by inhibiting spermPMN binding. Here we report that SP protein suppresses spermPMN binding in vitro in a dose-dependent manner, and that SP increases the fertility rate of mares inseminated with fertile spermatozoa 12 h after the induction of uterine inflammation by inoculation of killed spermatozoa.
| Materials and Methods |
|---|
|
|
|---|
Semen collection and isolation of fresh spermatozoa
Semen was collected from stallions of known fertility by the use of a Missouri model artificial vagina (Nasco, Fort Atkinson, WI, USA) equipped with an in-line gel filter (Animal Reproduction Systems, Chino, CA, USA). Semen volume was recorded, and sperm concentration and the percentage of progressively motile spermatozoa were determined. Semen was extended 1:3 with a skim-milk-based extender (SME; Kenneys extender, Har-Vet Inc., Spring Valley, WI, USA) and SP was removed by centrifugation at 400 g for 10 min. The spermatozoa pellet was washed in semen extender in order to remove all SP, and the sperm cells were resuspended in the corresponding media depending on the experiment. All sperm samples were adjusted to a concentration of 50 x 106 sperm cells/ml, and kept at room temperature (2325 °C). Only sperm cells with progressive motility of
50% were utilized.
Preparation of SP
SP was collected by centrifugation of fresh semen at 400 g for 10 min to remove the bulk of sperm cells. An additional centrifugation at 3000 g for 20 min was performed to eliminate all sperm cells. Equal amounts of SP from each of three stallions were pooled and the antibiotics used in the semen extender were added to the SP pool (amikacin sulfate (500 µg/ml), potassium penicillin G (1500 IU/ml); Brinsko & Varner 1992). A culture swab was taken 20 min after the addition of the antibiotics and SP was then divided into 30 ml aliquots and frozen at 20 °C until used. Only bacteriologically negative SP preparations were used.
Preparation of killed spermatozoa
Semen was collected from two stallions of normal fertility, evaluated and extended 1:3 with semen extender as described above. Spermatozoa were removed from SP by centrifugation at 400 g for 10 min. An equal number of sperm cells were pooled and the sperm pellet was washed twice with PBS (pH 7.2). Sperm cells were layered over a Percoll gradient (Sigma), and pelleted by centrifugation at 800 g for 30 min. Sperm cells were recovered from the bottom layer, resuspended in PBS and washed twice. All materials and solutions were sterilized and sperm processing was performed under sterile conditions. A bacteriological culture sample was obtained from the pooled spermatozoa and the remainder were divided into 2 ml aliquots each containing 1 x 109 spermatozoa. Spermatozoa were killed by snap freezing in liquid nitrogen and were stored frozen at 20 °C until used. Only sperm preparations with negative bacteriological cultures were used in the experiment.
SP protein preparation
Proteins were precipitated from the pooled SP with ammonium sulfate (33% w/v), collected by centrifugation (2000 g/15 min) and resuspended in a volume of PBS (pH 7.2) equal to the amount of SP used for precipitation so that the protein concentration was similar to that of the original SP. Both the proteinaceous and non-proteinaceous portions of SP were dialyzed against two changes of PBS overnight at 4 °C in a dialysis cassette with 3500 Molecular weight cut off (Slide-A-Lyzer, Pierce, Rockford, IL, USA). Blood plasma and the SME were processed similarly for use as control proteins of non-SP origin. Another SP-protein batch was similarly prepared with the exception that the protein was resuspended in PBS at a concentration of 40 mg/ml for use in the quantification experiment.
Preparation of PMNs
At the time of semen collection, blood was collected from a healthy mare and PMNs were isolated as previously described (Troedsson et al. 1993). Briefly, heparinized blood was subjected to centrifugation, the buffy coat was layered over a lymphocyte separation medium (Litton Bionetics, Kensington, MD, USA) and the PMNs were recovered from the buffy coat. The PMNs were washed and re-suspended in PBS at a concentration of 14 x 106/ml.
Evaluation of spermPMN binding
Wet mounts of sperm binding to PMNs were evaluated by light microscopy and expressed as the proportion of PMNs that bound to at least one spermatozoon. A drop of the spermPMN mix was placed on a glass slide, covered with a cover slip and the number of sperm-bound PMNs was determined using x 400 power. A minimum of 200 PMNs were counted for each slide. Sperm binding to PMNs from uterine secretions was studied at 1 h intervals for a total of 4 h at room temperature. However, the effect of SP proteins on sperm binding to blood-derived PMNs was determined after spermatozoa were first incubated with SP protein (37 °C for 30 min) followed by another incubation with PMNs, under the same conditions.
Uterine secretions
Five mares were inseminated with 1 x 109 spermatozoa with at least 50% progressive motility and uterine secretion samples were collected 12 h later using cotton tampons as previously described (Troedsson et al. 1993, Alghamdi et al. 2001). The tampon was recovered by the use of a vaginal speculum and placed in a small, sterilized plastic bag to prevent evaporation. Uterine secretions were retrieved from the tampon by the use of an Arbor press within 10 min of collection and the volume was recorded. All samples were transferred to the laboratory for use immediately after collection. Uterine secretions were then mixed with fresh sperm preparations at a 1:2 ratio and spermPMN binding was evaluated at 0, 60, 120, 180 and 240 min at room temperature.
Induction of uterine inflammation, and management and insemination for fertility trials
Eleven mares were used and each mare was utilized in four consecutive estrus cycles in a 2 x 2 factorial experiment. The factors were: (1) challenge (induction of uterine inflammation by either killed spermatozoa suspended in semen extender or semen extender alone); (2) fertile insemination (FI; with fertile spermatozoa suspended in SP or in semen extender). Before the start of the experiment, mares were assigned randomly to these treatments. Once a mare was detected to be in estrus and had a negative cytology, uterine inflammation was induced with either killed spermatozoa suspended in 30 ml semen extender or 30 ml semen extender alone depending on the assigned treatment. Mares were given 3000 U human chorionic gonadotropin (hCG; InterVet International B.V., Boxmeer, Holland) at the time of killed spermatozoa inoculation in order to shorten and standardize the interval from AI to ovulation. Twelve hours later, mares were inseminated with fertile spermatozoa suspended in either SP or semen extender depending on the assigned order. If a mare did not ovulate within 48 h after fertile AI, she was excluded from the experiment, treated with prostaglandin F2
(PGF2
; Estrumate, Miles, Inc., Shawnee Mission, KS, USA) 5 days after ovulation, and the treatment was repeated during the next estrus. Pregnancy was determined by transrectal ultrasonography at 11 and 15 days after ovulation. When diagnosed pregnant at day 15, an injection of 10 mg PGF2
was given to all mares to return them to estrus and prepare them for the next treatment.
SP protein digestion
To determine if the immunosuppressive factor in SP was a proteinaceous compound, 1 ml aliquots of precipitated SP proteins (12 mg/ml) were incubated at 56 °C for 3 h with proteinase K (PK; 100 µg/ml; Promega). To control for any effect of PK on the binding assay or motility, a PK inhibitor, phenylmethanesulfonyl fluoride (PMSF; 40 µg/ml; Roche), was included either at the time of PK addition or after the digestion was completed. Serial concentrations of PK and PMSF, and the incubation conditions, were determined in preliminary experiments. The possible effect of PMSF on motility and binding assay was controlled by treating SP protein with PMSF alone. Untreated SP protein controls were either heated similarly to the other treatments or used without heating. Sperm cells were incubated in these preparations for 30 min at 37 °C followed by the addition of PMNs as described above and the binding was compared with sperm cells incubated in SME alone. Digestion of SP protein was confirmed by SDS-PAGE.
Statistical analysis
Data for spermPMN binding in uterine secretion were analyzed using a general linear model (GLM) for repeated measures with mares, ejaculates and concentrations of SP included in the model as independent variables. Following GLM, the means were further analyzed by the least-square mean procedure. Fertility data were analyzed by the logistic regression procedure. The challenge and the FI were included in the model as independent variables. The fit of the model was examined by the deviance and its P value and was further checked with the WilkShapiro/Rankit plot. The 95% confidence interval for the odds ratio was requested after determination of the logistic regression to determine how likely it is that each factor influences the pregnancy outcome. Sperm- and blood-derived PMN binding data were analyzed using general ANOVA, and stallions and ejaculates were included in the model as independent variables. Following ANOVA analysis, the means were compared using the Bonferroni procedure. For all data analysis, statistical significance was set at P
0.05.
| Results |
|---|
|
|
|---|
|
and were reused during the subsequent estrus. There was no significant difference in pregnancy rates in mares inoculated with dead spermatozoa (9/22) or semen extender alone (9/22). Therefore, these groups were combined for further statistical analysis to determine the effect of SP on pregnancy. The pregnancy rate at 15 days after ovulation was significantly (P < 0.05) higher in mares inseminated with fertile sperm cells suspended in SP (17/22) compared with mares inseminated with fertile sperm cells suspended in semen extender (1/22; Fig. 2
|
|
|
|
|
| Discussion |
|---|
|
|
|---|
The reduced sperm motion characteristics of spermatozoa incubated in uterine secretions containing PMNs may suggest that fewer or no sperm cells will reach the oviduct in the presence of PMNs. However, some sperm cells seemed to be resistant to PMN binding, suggesting heterologous sperm populations with two or more subpopulations (Alghamdi et al. 2001). Insemination with fertile spermatozoa 12 h after inducing uterine inflammation, and in the absence of SP, resulted in only one pregnancy (5%). The suppressive properties of SP on spermPMN binding effectively protected more spermatozoa from binding to PMNs, and being subsequently phagocytosed, before reaching the oviduct, since pregnancy rates were higher in this group (77%). In rabbits, double mating resulted in pregnancies from the second mating despite the need for the second deposit of spermatozoa to traverse the inflamed cervix and uterus (Taylor 1982). When the second mating of rabbits was performed within 1 h of the first, the fertility of the buck determined the pregnancy rates. However, when 4 h elapsed, pregnancy rates were always lower from the second mating regardless of the bucks fertility (Taylor 1982).
The results from the breeding trial are supported by a similar study in sows, in which SP significantly improved conception and farrowing rates in sows inseminated with fertile spermatozoa in the presence of an ongoing uterine inflammation (Rozeboom et al. 2000). The higher pregnancy rate in mares inseminated with fertile spermatozoa suspended in SP may also explain the high pregnancy rates that have been observed in wild horses, despite their mating behavior with frequent breedings during estrus (Bristol 1987). Since man-controlled natural breeding and AI with fresh semen is commonly repeated at intervals of 48 h, uterine clearance in normal mares would have been completed by the time of the second breeding. However, the shorter life span of preserved spermatozoa, and the difficult task of accurately predicting the time of ovulation, often forces practitioners and breeders to inseminate mares repeatedly at intervals that can be as short as 6 or 12 h until ovulation. Although this breeding management assures the presence of newly inseminated spermatozoa in the uterus, it does not guarantee that spermatozoa will survive the inflammatory uterine environment and reach the oviduct at the time of ovulation. The normal pregnancy rate of mares inseminated with fertile spermatozoa suspended in SP despite the presence of uterine inflammation strongly suggests an important role of SP in fertility. This is especially relevant in situations of repeated breedings and may be important in mares suffering from delayed uterine clearance where retained PMNs may interfere with sperm transport.
Our results show that the immunosuppressive component of SP is a proteinaceous substance, which could be a peptide(s), a protein(s), a lipoprotein(s), a glycoprotein(s) or a proteoglycan(s). Ammonium sulfate precipitation, dialysis and freezing did not inactivate the effective substance in the SP. In addition, heating for 3 h at 56 °C still did not inactivate the effective component in SP, as was expected based on the previous finding that this immunosuppressive component was not inactivated unless heated at 95 °C for 45 min (Dahmes & Troedsson 2002). A concentration of 6 mg/ml was sufficient to reduce spermPMN binding to levels similar to that achieved with whole SP. The dose-dependent reduction of spermPMN binding in relation to the amount of SP protein is in agreement with the dose-dependent reduction of phagocytosis and chemotaxis by the addition of SP in the mare, and chemotaxis in the sow (Troedsson et al. 2000, Rozeboom et al. 2001). The finding that proteins precipitated from blood plasma and semen extender did not reduce spermPMN binding demonstrates that this suppression of binding was specific to SP. Whether there are one or more SP molecule(s) responsible for suppression of spermPMN binding is not known, and should be determined.
Ammonium sulfate precipitation (33% w/v) was effective in collecting the immunosuppressive component but, as seen in Fig. 5
, some proteins of approximately 83 kDa or greater were not precipitated. This is consistent with a series of preliminary experiments where ammonium sulfate at between 5 and 25% essentially precipitated no SP proteins, while the majority of proteins were precipitated by concentrations of 3035% (w/v). Once the majority of SP proteins were precipitated using 33% ammonium sulfate, increasing the concentration to 50% resulted in a negligible increase in precipitated proteins. PK digested SP protein completely and destroyed the immunosuppressive action of SP protein. This is a strong indication that the effective molecule is a proteinaceous component(s). In addition, this immunosuppressant SP protein(s) appears to be resistant to heating for up to 3 h at 56 °C.
In conclusion, a proteinaceous substance(s) from equine SP reduces spermPMN binding in vitro, and SP improves fertility of fresh spermatozoa inseminated into inflamed uteri. This substance(s) can be precipitated from SP, heated for up to 3 h at 56 °C and stored frozen without losing its biological properties. A total of 6 mg/ml crude precipitated SP protein prevented spermPMN binding to a level similar to that achieved with fresh whole SP.
| Acknowledgements |
|---|
|
|
|---|
| Footnotes |
|---|
| References |
|---|
|
|
|---|
Alghamdi A, Troedsson MHT, Laschkewitsch T & Xue J-L 2001 Uterine secretion from mares with post-breeding endometritis alters sperm motion characteristics in vitro. Theriogenology 55 10191028.[CrossRef][ISI][Medline]
Anderson DJ & Tarter TH 1982 Immunosuppressive effects of mouse seminal plasma components in vivo and in vitro. Journal of Immunology 128 535539.[Abstract]
Bouvet JP, Couderc J & Pillot J 1987 In vivo and in vitro immunosuppressions in mice by a 100110-Kd fraction from boar seminal plasma. American Journal of Reproductive Immunology and Microbiology 14 135140.[ISI][Medline]
Brinsko SP & Varner DD 1992 Artificial insemination and preservation of semen. Veterinary Clinics of North America: Equine Practice 8 205218.
Bristol F 1987 Fertility of pasture bred mares in synchronized oestrus. Journal of Reproduction and Fertility Supplement 35 3943.
Dahmes BJ & Troedsson MHT 2002 The effect of seminal plasma components on opsonisation and PMN-phagocytosis of equine spermatozoa. Theriogenology 58 457460.[CrossRef][ISI]
Imade GE, Baker HW, de Kretser DM & Hedger MP 1997 Immunosuppressive activities in the seminal plasma of infertile men: relationship to sperm antibodies and autoimmunity. Human Reproduction 12 256262.
Katila T 1995 Onset and duration of uterine inflammatory response of mares after insemination with fresh semen. Biology of Reproductive Monograph Series 1 515517.
Katila T, Celebi M & Koskinen E 1996 Effect of timing of frozen semen insemination on pregnancy rate in mares. Acta Veterinaria Scandinavica 37 361365.[ISI][Medline]
Kenney RM & Doig PA 1986 Equine endometrial biopsy. In Current Therapy in Theriogenology 2, pp 723729. Ed. DA Morrow. Philadelphia: WB Saunders.
Kloppe LH, Varner DD, Elmore RG, Bretzlaff KN & Shull JW 1988 Effect of insemination timing on fertilizing capacity of frozen/thawed equine spermatozoa. Theriogenology 29 429439.[CrossRef][ISI][Medline]
Kotilainen T, Huhtinen M & Katila T 1994 Sperminduced leukocytosis in the equine uterus. Theriogenology 41 629636.
McKinnon AO 1996 Artificial insemination of cooled, transported and frozen semen. Australian Equine Veterinarian 14 154175.
McKinnon AO & Voss JL 1993 Equine Reproduction. Philadelphia: Lea and Febiger.
Ricci G, Perticarari S, Fragonas E, Giolo E, Canova S, Pozzobon C, Guaschino S & Presani G 2002 Apoptosis in human sperm: its correlation with semen quality and the presence of leukocytes. Human Reproduction 17 26652672.
Rozeboom KJ, Troedsson MH, Molitor TW & Crabo BG 1999 The effect of spermatozoa and seminal plasma on leukocyte migration into the uterus of gilts. Journal of Animal Science 77 22012206.
Rozeboom KJ, Troedsson MH, Hodson HH, Shurson GC & Crabo BG 2000 The importance of seminal plasma on the fertility of subsequent artificial inseminations in swine. Journal of Animal Science 78 443448.
Rozeboom KJ, Rocha-Chavez G & Troedsson MH 2001 Inhibition of neutrophil chemotaxis by pig seminal plasma in vitro: a potential method for modulating post-breeding inflammation in sows. Reproduction 121 567572.[Abstract]
Schope RE, Schramm P, Benes P & Morsches B 1984 Seminal plasma-induced suppression of the respiratory burst of polymorphonuclear leukocytes and monocytes. Andrologia 16 124128.[ISI][Medline]
Shore MD, Macpherson ML, Combes GB, Varner DD & Blanchard TL 1998 Fertility comparison between breeding at 24 hours or at 24 and 48 hours after collection with cooled equine semen. Theriogenology 50 693698.[CrossRef][ISI][Medline]
Taylor NJ 1982 Investigation of sperm-induced cervical leucocytosis by a double mating study in rabbits. Journal of Reproduction and Fertility 66 157160.[Abstract]
Tomlinson MJ, White A, Barratt CL, Bolton AE & Cooke ID 1992 The removal of morphologically abnormal sperm forms by phagocytes: a positive role for seminal leukocytes? Human Reproduction 7 517522.
Troedsson MHT 1999 Uterine clearance and resistance to persistent endometritis in the mare. Theriogenology 52 461471.[CrossRef][ISI][Medline]
Troedsson MHT, Liu IKM & Thurmond M 1993 Function of uterine and blood-derived polymorphonuclear neutrophils in mares susceptible and resistant to chronic uterine infection: phagocytosis and chemotaxis. Biology of Reproduction 49 507514.[Abstract]
Troedsson MHT, Steiger BN, Ibrahim NM, King VL, Foster DN & Crabo BG 1995a Mechanism of sperm-induced endometritis in the mare. Biology of Reproduction 52 (Suppl) 133.
Troedsson MHT, Crabo BG, Ibrahim NM, Scott M & Ing M 1995b Mating-induced endometritis: mechanism, clinical importance, and consequences. Proceedings of the American Association of Equine Practitioners 41 1112.
Troedsson MHT, Liu IKM & Crabo BG 1998 Sperm transport and survival in the mare: a review. Theriogenology 50 807818.[CrossRef][ISI][Medline]
Troedsson MHT, Lee C-S, Franklin RD & Crabo BG 2000 The role of seminal plasma in post-breeding uterine inflammation. Journal of Reproduction and Fertility Supplement 56 341349.
Troedsson MHT, Loset K, Alghamdi AM, Dahms B & Crabo BG 2001 Interaction between equine semen and the endometrium: the inflammatory response to semen. Animal Reproduction Science 68 273278.[CrossRef][ISI][Medline]
Woods J, Bergfelt DR & Ginther OJ 1990 Effect of time of insemination relative to ovulation on pregnancy rate and embryonic-loss rate in mares. Equine Veterinary Journal 22 410415.[ISI][Medline]
This article has been cited by other articles:
![]() |
M. L. Vadnais and K. P. Roberts Effects of Seminal Plasma on Cooling-Induced Capacitative Changes in Boar Sperm J Androl, May 1, 2007; 28(3): 416 - 422. [Abstract] [Full Text] [PDF] |
||||
![]() |
A. S. Alghamdi and D. N. Foster Seminal DNase Frees Spermatozoa Entangled in Neutrophil Extracellular Traps Biol Reprod, December 1, 2005; 73(6): 1174 - 1181. [Abstract] [Full Text] [PDF] |
||||
| ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH | TABLE OF CONTENTS |